Bill > SB5240

This bill modifies existing Washington state law regarding anaphylaxis medications in schools, expanding and clarifying provisions for managing severe allergic reactions. The bill allows school districts and private schools to maintain a supply of epinephrine (a medication used to treat life-threatening allergic reactions) and epinephrine autoinjectors, which can be prescribed by licensed health professionals in the name of the school. The legislation ensures that schools can use epinephrine both for students with existing prescriptions and for students without prior prescriptions during an emergency. The bill also provides liability protections for school employees who administer epinephrine in substantial compliance with school policies and prescriptions, and requires schools to reimburse the cost of epinephrine if it is not school-owned. Additionally, the bill mandates that the Office of the Superintendent of Public Instruction, in consultation with the Department of Health, develop comprehensive policy guidelines for preventing and responding to anaphylaxis, including training requirements for school personnel, communication plans, and strategies for reducing allergen exposure. The guidelines apply to all public schools, charter schools, and state-tribal education compact schools, ensuring a consistent approach to managing severe allergic reactions across different types of educational institutions.